Cognitass er fotfestet i hverdagen - Cognita
Anita Sveen - Institutt for klinisk medisin
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
ANITA SVEEN Wettre, Biri | person | gulesider.no
Ny kunnskap om tarmkreft med spredning - Kreftforeningen
Anita SVEEN | Oslo University Hospital, Oslo
Vårt motto er å gjøre det umulige... - Oslo universitetssykehus | Facebook
Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum for her research accomplishments - K.G. Jebsen Colorectal Cancer Research Centre
OUH - News
OUH - Molecular Oncology
Anita SVEEN | Oslo University Hospital, Oslo
Sammen blir det bedre
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for
Anita SVEEN | Oslo University Hospital, Oslo
Stiftelse støtter norsk medisinsk forskning med 48 millioner - Tu.no
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.,Oncogenesis - X-MOL
Anita SVEEN | Oslo University Hospital, Oslo
PDF) Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
OUH - Group members
Biomarker-guided therapy for colorectal cancer: strength in complexity.,Nature Reviews Clinical Oncology - X-MOL
OUH - Molecular Oncology
OUH - OUS-research.no
OUH - OUS-research.no
ANITA Sveen, Karmsund | person | gulesider.no
Vinner av årets tema-konkurranse er Anita Sveen – Skauge Forlag
